Review



multitargeted tki sunitinib sutent  (Pfizer Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Pfizer Inc multitargeted tki sunitinib sutent
    Multitargeted Tki Sunitinib Sutent, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitargeted+tkis+sunitinib/pmc03333816-85-15-21?v=Pfizer+Inc
    Average 90 stars, based on 1 article reviews
    multitargeted tki sunitinib sutent - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    multitargeted tyrosine kinase inhibitors sunitinib malate  (Selleck Chemicals)
    93
    Selleck Chemicals multitargeted tyrosine kinase inhibitors sunitinib malate
    Figure 1. MiR-302/520 miRNA family increases susceptibility of GBM cells to <t>sunitinib</t> treatment. a) Overview
    Multitargeted Tyrosine Kinase Inhibitors Sunitinib Malate, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitargeted+tkis+sunitinib/pm28973155-167-3-14?v=Selleck+Chemicals
    Average 93 stars, based on 1 article reviews
    multitargeted tyrosine kinase inhibitors sunitinib malate - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    multitargeted tki sunitinib sutent  (Pfizer Inc)
    90
    Pfizer Inc multitargeted tki sunitinib sutent
    Figure 1. MiR-302/520 miRNA family increases susceptibility of GBM cells to <t>sunitinib</t> treatment. a) Overview
    Multitargeted Tki Sunitinib Sutent, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitargeted+tkis+sunitinib/pmc03333816-85-15-21?v=Pfizer+Inc
    Average 90 stars, based on 1 article reviews
    multitargeted tki sunitinib sutent - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    multitargeted tkis sunitinib  (Pfizer Inc)
    90
    Pfizer Inc multitargeted tkis sunitinib
    Figure 1. MiR-302/520 miRNA family increases susceptibility of GBM cells to <t>sunitinib</t> treatment. a) Overview
    Multitargeted Tkis Sunitinib, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitargeted+tkis+sunitinib/pmc02913528-311-6-13?v=Pfizer+Inc
    Average 90 stars, based on 1 article reviews
    multitargeted tkis sunitinib - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1. MiR-302/520 miRNA family increases susceptibility of GBM cells to sunitinib treatment. a) Overview

    Journal: Human molecular genetics

    Article Title: High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.

    doi: 10.1093/hmg/ddx323

    Figure Lengend Snippet: Figure 1. MiR-302/520 miRNA family increases susceptibility of GBM cells to sunitinib treatment. a) Overview

    Article Snippet: Temozolomide and the multitargeted tyrosine kinase inhibitors sunitinib malate and axitinib were acquired from Selleckchem (Houston, USA) and stored at 20 C in DMSO.

    Techniques:

    Figure 3. Combination of miRNA-302a/520b expression with multitargeted tyrosine kinase inhibitors decreases GBM cell viability. U87 and DBTRG cells were transfected with 50 nM of miRNA-302a, miR-520b or

    Journal: Human molecular genetics

    Article Title: High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.

    doi: 10.1093/hmg/ddx323

    Figure Lengend Snippet: Figure 3. Combination of miRNA-302a/520b expression with multitargeted tyrosine kinase inhibitors decreases GBM cell viability. U87 and DBTRG cells were transfected with 50 nM of miRNA-302a, miR-520b or

    Article Snippet: Temozolomide and the multitargeted tyrosine kinase inhibitors sunitinib malate and axitinib were acquired from Selleckchem (Houston, USA) and stored at 20 C in DMSO.

    Techniques: Expressing, Transfection

    Figure 5. Cellular DNA content increases upon miR-302a transfection and treatment with multitargeted tyrosine kinase inhibitors. Cells were incubated with miR-302a or control miRNA (cel-miR-239b) mimics for

    Journal: Human molecular genetics

    Article Title: High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.

    doi: 10.1093/hmg/ddx323

    Figure Lengend Snippet: Figure 5. Cellular DNA content increases upon miR-302a transfection and treatment with multitargeted tyrosine kinase inhibitors. Cells were incubated with miR-302a or control miRNA (cel-miR-239b) mimics for

    Article Snippet: Temozolomide and the multitargeted tyrosine kinase inhibitors sunitinib malate and axitinib were acquired from Selleckchem (Houston, USA) and stored at 20 C in DMSO.

    Techniques: Transfection, Incubation, Control